Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5 USD | -2.53% | -8.42% | -60.16% |
Apr. 22 | Citigroup Starts agilon health With Neutral Rating, $6 Price Target | MT |
Mar. 06 | Barclays Initiates Agilon Health With Underweight Rating, Price Target is $5 | MT |
Financials (USD)
Sales 2024 * | 6.4B | Sales 2025 * | 7.96B | Capitalization | 2.06B |
---|---|---|---|---|---|
Net income 2024 * | -146M | Net income 2025 * | -82M | EV / Sales 2024 * | 0.29 x |
Net cash position 2024 * | 176M | Net cash position 2025 * | 164M | EV / Sales 2025 * | 0.24 x |
P/E ratio 2024 * |
-14.1
x | P/E ratio 2025 * |
-25.3
x | Employees | 1,117 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.12% |
Latest transcript on agilon health, inc.
1 day | -2.53% | ||
1 week | -8.42% | ||
Current month | -18.03% | ||
1 month | +0.20% | ||
3 months | -14.09% | ||
6 months | -72.78% | ||
Current year | -60.16% |
Managers | Title | Age | Since |
---|---|---|---|
Veeral Desai
FOU | Founder | 43 | 15-12-31 |
Steven Sell
CEO | Chief Executive Officer | 57 | 20-05-31 |
Timothy Bensley
DFI | Director of Finance/CFO | 64 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Sell
CEO | Chief Executive Officer | 57 | 20-05-31 |
Ronald Williams
FOU | Founder | 74 | 15-12-31 |
Sharad Mansukani
BRD | Director/Board Member | 54 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.94% | 8 M€ | +2.44% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 5 | -2.53% | 2,409,005 |
24-04-25 | 5.13 | -3.75% | 2,868,012 |
24-04-24 | 5.33 | -0.19% | 2,698,593 |
24-04-23 | 5.34 | +3.49% | 2,232,307 |
24-04-22 | 5.16 | -5.49% | 4,260,966 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.16% | 2.06B | |
-21.25% | 2.91B | |
-20.94% | 2.67B | |
-25.10% | 323M | |
-4.99% | 211M | |
-47.38% | 172M | |
-27.37% | 123M |
- Stock Market
- Equities
- AGL Stock